Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Merrimack Pharmaceuticals Inc. (MACK) just unveiled an announcement.
Merrimack Pharmaceuticals, Inc. stockholders have overwhelmingly voted to approve the company’s liquidation and dissolution, with a substantial majority supporting the proposal in a Special Meeting held virtually. Following this approval, the company announced a significant liquidating cash dividend of $15.10 per share, expected to be paid shortly before Merrimack’s delisting from NASDAQ. While the future may hold additional distributions contingent on certain milestones, the company cautions that these forward-looking statements are subject to change and uncertainty.
See more data about MACK stock on TipRanks’ Stock Analysis page.